NISUY yields 1.03% · PFE yields 6.13%● Live data
📍 NISUY pulled ahead of the other in Year 1
Combined, NISUY + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of NISUY + PFE for your $10,000?
Nissui Corporation engages in marine, food products, fine chemicals, distribution, and marine-related/engineering businesses in Japan and internationally. The company engages in the provision of salmon, Alaska pollock, yellowtail, shrimp, tuna, crab, and yellowtail products, as well as fish feed, oil, and meal products. It also produces and sells frozen foods for household and food service use, shelf-stable foods, and fish sausage and surimi-based products, as well as chilled foods. In addition, the company produces and supplies fine chemical products, such as eicosapentaenoic acid (EPA) for pharmaceuticals; and ingredients for functional foods, health products, supplements, and other health-related foods that contain EPA. Further, it is involved in integrated logistics service business; and building, repairing, and operating ships. The company was formerly known as Nippon Suisan Kaisha, Ltd. and changed its name to Nissui Corporation in December 2022. The company was founded in 1911 and is headquartered in Tokyo, Japan.
Full NISUY Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.